Tetsuro Shishido Selected Research

Fatty Acid Binding Protein 3

2/2018	Gender differences in the impact of anemia on subclinical myocardial damage and cardiovascular mortality in the general population: The Yamagata (Takahata) study.
1/2018	Ventricular wall stress and silent myocardial damage are associated with pulse pressure in the general population.
5/2017	Combined assessment of myocardial damage and electrical disturbance in chronic heart failure.
3/2016	Circulating heart-type fatty acid-binding protein levels predict ventricular fibrillation in Brugada syndrome.
12/2015	Heart-type fatty acid binding protein and high-sensitivity troponin T are myocardial damage markers that could predict adverse clinical outcomes in patients with peripheral artery disease.
1/2014	Association of heart-type fatty acid-binding protein with cardiovascular risk factors and all-cause mortality in the general population: the Takahata study.
7/2012	Circulating heart-type fatty acid binding protein levels predict the occurrence of appropriate shocks and cardiac death in patients with implantable cardioverter-defibrillators.
1/2012	Impact of insulin resistance on silent and ongoing myocardial damage in normal subjects: the Takahata study.
10/2005	Ongoing myocardial damage relates to cardiac sympathetic nervous disintegrity in patients with heart failure.
8/2005	Combination of heart-type fatty acid binding protein and brain natriuretic peptide can reliably risk stratify patients hospitalized for chronic heart failure.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tetsuro Shishido Research Topics

Disease

27	Heart Failure 02/2020 - 11/2004
21	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 07/2005
14	Myocardial Infarction 01/2021 - 12/2003
9	Cardiomegaly (Heart Hypertrophy) 12/2020 - 10/2005
8	Peripheral Arterial Disease 01/2020 - 01/2015
5	Hypertrophy 12/2020 - 03/2005
5	Infarction (Infarctions) 10/2017 - 04/2006
5	Atrial Fibrillation 01/2016 - 01/2011
4	Stroke (Strokes) 07/2019 - 05/2012
4	Diabetes Mellitus 11/2018 - 08/2008
4	Coronary Artery Disease (Coronary Atherosclerosis) 08/2016 - 04/2014
4	Ischemia 04/2016 - 04/2006
4	Inflammation (Inflammations) 04/2014 - 07/2006
4	Death (Near-Death Experience) 07/2012 - 10/2005
3	Anemia 01/2019 - 05/2014
3	Myocardial Ischemia (Ischemic Heart Diseases) 11/2018 - 05/2006
3	Insulin Resistance 08/2016 - 10/2006
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2016 - 01/2011
3	Renal Insufficiency (Renal Failure) 05/2016 - 10/2005
3	Reperfusion Injury 12/2015 - 05/2006
3	Cardiomyopathies (Cardiomyopathy) 05/2015 - 08/2008
3	Body Weight (Weight, Body) 02/2014 - 01/2006
3	Fibrosis (Cirrhosis) 09/2013 - 12/2003
2	Coronary Stenosis (Coronary Artery Stenosis) 03/2021 - 01/2019
2	Coronary Vasospasm (Coronary Artery Vasospasm) 01/2019 - 01/2011
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 07/2018 - 01/2011
2	Atherosclerosis 01/2018 - 01/2016
2	Stable Angina 12/2017 - 09/2014
2	Acute Coronary Syndrome 12/2017 - 09/2014
2	Chronic Limb-Threatening Ischemia 02/2017 - 12/2015
2	Shock 12/2016 - 03/2016
2	Chronic Renal Insufficiency 05/2016 - 01/2011
2	Heart Injuries 03/2016 - 07/2012
2	Cardiotoxicity 01/2016 - 05/2015
2	Sarcopenia 03/2015 - 01/2015
2	Obesity 05/2014 - 01/2014
2	Ventricular Remodeling 02/2007 - 12/2003
1	Abdominal Aortic Aneurysm 03/2021
1	Aneurysm (Aneurysms) 03/2021
1	Vascular Remodeling 01/2020
1	Right Ventricular Hypertrophy 01/2020

Drug/Important Bio-Agent (IBA)

11	Fatty Acid Binding Protein 3IBA 02/2018 - 07/2005
8	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021 - 08/2005
8	Proteins (Proteins, Gene)FDA Link 12/2020 - 02/2004
6	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 07/2006
6	Fatty Acid-Binding ProteinsIBA 02/2018 - 07/2005
5	CreatinineIBA 02/2020 - 10/2005
4	UbiquitinIBA 12/2020 - 06/2008
4	MidkineIBA 01/2020 - 04/2010
4	Biomarkers (Surrogate Marker)IBA 07/2019 - 08/2012
4	Troponin T (Troponin T1)IBA 07/2019 - 07/2012
4	Cystatin CIBA 10/2016 - 10/2005
4	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 10/2005
4	Messenger RNA (mRNA)IBA 01/2016 - 12/2003
4	Diacylglycerol KinaseIBA 01/2014 - 03/2005
4	Angiotensin IIIBA 09/2013 - 10/2005
3	Xanthine DehydrogenaseIBA 01/2020 - 02/2017
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 01/2014
3	Atrial Natriuretic Factor (ANF)IBA 07/2019 - 03/2005
3	HMGB1 Protein (HMG1)IBA 10/2017 - 09/2013
3	Collagen Type I (Type I Collagen)IBA 02/2017 - 12/2003
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 06/2008
3	Protein Kinase CIBA 01/2014 - 03/2005
3	DiglyceridesIBA 01/2014 - 01/2006
3	CytokinesIBA 01/2013 - 07/2006
3	EnzymesIBA 07/2011 - 10/2005
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2020 - 01/2016
2	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2020 - 01/2016
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 05/2016
2	pro-brain natriuretic peptide (1-76)IBA 07/2019 - 01/2019
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2017 - 09/2014
2	LipidsIBA 12/2017 - 01/2011
2	DNA-Binding Proteins (DNA Binding Protein)IBA 10/2017 - 05/2015
2	CollagenIBA 02/2017 - 01/2016
2	Uric Acid (Urate)IBA 08/2016 - 04/2007
2	ThioredoxinsIBA 01/2016 - 11/2014
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2016 - 08/2008
2	Interleukin-6 (Interleukin 6)IBA 01/2016 - 12/2015
2	PTX3 proteinIBA 12/2015 - 01/2013
2	Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA 01/2015 - 10/2011
2	AdipokinesIBA 05/2014 - 04/2014
2	Ligases (Synthetase)IBA 02/2012 - 12/2010
2	ImmunosorbentsIBA 07/2011 - 04/2007
2	90-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 90 kDa)IBA 08/2008 - 05/2006
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 02/2007 - 12/2003
2	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 02/2007 - 01/2006
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2004 - 12/2003
1	CateninsIBA 12/2020
1	locked nucleic acidIBA 01/2020
1	AGRO 100IBA 01/2020

Therapy/Procedure

12	Therapeutics 03/2021 - 11/2007
5	Patient Readmission 07/2018 - 10/2005
4	Percutaneous Coronary Intervention 01/2021 - 01/2013
4	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 12/2016 - 01/2011
3	Secondary Prevention 12/2017 - 05/2012
3	Catheter Ablation 01/2016 - 01/2011
2	Nephrectomy 05/2016 - 10/2005
1	Perioperative Period 03/2021
1	Endovascular Aneurysm Repair 03/2021
1	Aftercare (After-Treatment) 01/2020